治疗慢性乙型肝炎病毒：中国医生“2010年准则的认识

StephenW

World J Hepatol. 2016 Jun 28;8(18):762-9. doi: 10.4254/wjh.v8.i18.762.
Treating chronic hepatitis B virus: Chinese physicians' awareness of the 2010 guidelines.Wei L1, Jia JD1, Weng XH1, Dou XG1, Jiang JJ1, Tang H1, Ning Q1, Dai QQ1, Li RQ1, Liu J1.
Author information

• 1Lai Wei, Department of Hepatology, Peking University People's Hospital, Beijing 100044, China.
  

AbstractAIM: To investigate Chinese physicians' awareness of the 2010 guidelines on the treatment of chronic hepatitis B virus (HBV) infection.
METHODS: This was a quantitative survey that investigated the characteristics and practices of physicians who were treating patients with hepatitis B, the profile of their patients and physician practices regarding the diagnosis and treatment of HBV at the time of the survey. Participants were randomly selected from available databases of Chinese physicians and requested to complete either an online or paper-based survey. Data from the survey responses were analysed. For data validation and interpretation, qualitative indepth interviews were conducted with 39 of the respondents.
RESULTS: Five-hundred completed surveys, from 663 physicians were available for analysis. A mean of 175 chronic hepatitis B (CHB) patients was seen by each physician every month, of whom 85 (49%) were treated in line with therapeutic indications stated in the 2010 guidelines. A total of 444 (89%) physicians often (> 60% of the time) adhered to the guidelines. Most physicians used antiviral medications as recommended. For patients with compensated and decompensated cirrhosis, 342 (68%) and 336 (67%) of physicians, respectively, often followed the recommendation to use potent nucleos(t)ide analogues with a high genetic barrier to resistance, using the appropriate treatment more than 60% of the time. Physicians from infectious disease or liver disease departments were better informed than those from gastrointestinal or other departments.
CONCLUSION: The majority of Chinese physicians often adhere to Chinese 2010 CHB guidelines and are well-informed about the use of antiviral medications for hepatitis B.


KEYWORDS: Awareness; China; Chronic hepatitis B; Physicians; Practice guidelines

PMID:27366303DOI:10.4254/wjh.v8.i18.762

StephenW

世界肝脏病学杂志。 2016年6月28日; 8（18）：762-9。 DOI：10.4254 / wjh.v8.i18.762。
治疗慢性乙型肝炎病毒：中国医生“2010年准则的认识。
魏L1，贾JD1，翁XH1，窦XG1，江JJ1，唐H1，宁Q1，戴QQ1，李RQ1，刘J1。
作者信息

    1Lai卫，肝病，北京大学人民医院，北京100044，中国系。

抽象
目标：

为了研究中国医师治疗慢性乙型肝炎病毒（HBV）感染的治疗，2010年准则的认识。
方法：

这是调查的特点，谁是乙型肝炎，他们的病人和乙肝病毒方面在调查时的诊断和治疗医生的做法的轮廓治疗病人的医生实践的定量调查。参与者被随机从中国医师可用的数据库选择，并要求完成联机或纸质问卷调查。从调查的响应数据进行了分析。数据验证和解释，定性深入访谈与受访者进行的39。
结果：

五百完成调查，从663医生可供分析。 175慢性乙型肝炎（CHB）的患者，平均每个月需要看到每个医生，其中85（49％）与在2010年的规范中规定的治疗适应症线治疗。总共有444（89％）的医生经常（>的时间的60％）坚持的指导方针。大多数医生使用抗病毒药物的建议。对于患者与医生的补偿，失代偿期肝硬化，342（68％）和336（67％），分别之后往往使用强效的核苷（酸）类似物具有高耐药基因屏障的建议，使用适当的治疗更比的60％的时间。从感染性疾病或肝脏疾病部门医生均较胃肠道或其他部门更好地了解情况。
结论：

大多数中国医生经常坚持中国2010 CHB准则，并充分了解使用抗病毒药物对乙肝
关键词：

意识;中国;慢性乙型肝炎;医生;实践指南

结论：
    27366303
DOI：
    10.4254 / wjh.v8.i18.762